The SPC Manufacturing Waiver (the "Waiver") is now in force, effective from 1 July 2019 (Regulation 2019/933 amending the SPC Regulation 2009/469). The Waiver has been introduced with the stated aim of putting EU generic and...more
7/5/2019
/ Biosimilars ,
EU ,
Exports ,
Generic Drugs ,
Intellectual Property Protection ,
Manufacturers ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs ,
Regulatory Oversight ,
Regulatory Requirements ,
Supplementary Protection Certificate ,
Waivers
On Monday the UK government published a series of notices on the impact of a no-deal Brexit on intellectual property right-holders....more
9/28/2018
/ Copyright ,
EU ,
Geographically Descriptive ,
Intellectual Property Protection ,
Member State ,
Patent Exhaustion ,
Referendums ,
Supplementary Protection Certificate ,
Trademark Registration ,
Trademarks ,
UK ,
UK Brexit ,
Unified Patent Court ,
Unitary Patent